Top Markets
Coin of the day
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd

HLB Pharmaceutical Co., Ltd

047920
Rank in Stocks #19377
HLB Pharmaceutical Co., Ltd is a South Korean pharmaceutical firm dedicated to... HLB Pharmaceutical Co., Ltd is a South Korean pharmaceutical firm dedicated to the research and development of peptide-based drugs. Its product line encompasses a wide array of pharmaceutical preparations. These include medications for skeletal muscle relaxation, tranquilizing effects, antihistamine action, hypertension management, pain alleviation, anti-itching, astringent properties, anti-inflammatory relief, alimentary system support, metabolic regulation, ophthalmic conditions, local anesthesia, anti-arteriosclerosis, expectoration, fever reduction, analgesia, diabetes control, chemotherapy, peptic ulcer treatment, central nervous system issues, bacterial infections (antibiotics), digestive assistance, antacid needs, dental care, multivitamin supplementation, parasitic skin diseases, dermatological concerns, urogenital organ function, amino acid replacement, cough suppression, mucus thinning, parasitic worm elimination, diarrhea relief, circulatory system disorders, vitamin deficiencies, skin softening, hemorrhoid treatment, and liver ailments. Additionally, the company is actively developing CTT-004, an investigational therapy for ataxia associated with spinocerebellar degeneration, and offers Contract Manufacturing Organization (CMO) services. The enterprise, established in 1998, was formerly recognized as Mediforum Pharmaceutical Incorporation before adopting the name HLB Pharmaceutical Co., Ltd in October 2020. Its headquarters are located in Namyangju-Si, South Korea.
Share Price
$5.01
Market Cap
$164.43M
Change (1 day)
-4.98%
Change (1 year)
-48.54%
Country
KR
Trade HLB Pharmaceutical Co., Ltd (047920)

Category

Stock price history for HLB Pharmaceutical Co., Ltd (047920)
Highest end of day price: $5.74 on 2026-08-01

Lowest end of day price: $5.98 on 2015-12-01
Stock price history of HLB Pharmaceutical Co., Ltd from 2015 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -5.24%
2025 -31.57%
2024 45.66%
2023 13.74%
2022 -20.69%
2021 -24.31%
2020 249.25%
2019 15.40%
2018 -34.85%
2017 35.41%
2016 -27.22%
2015 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$165.29 31.69%
DE
$38.23 28.07%
JP
$223.18 30.81%
CH
$21.14 15.75%
IN